{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Class</th>\n",
       "      <th>Source</th>\n",
       "      <th>Alternate Names</th>\n",
       "      <th>Adverse Class</th>\n",
       "      <th>Single Drug</th>\n",
       "      <th>Classification of Risk</th>\n",
       "      <th>Mechanism</th>\n",
       "      <th>Adverse Effect</th>\n",
       "      <th>Unnamed: 8</th>\n",
       "      <th>Unnamed: 9</th>\n",
       "      <th>Unnamed: 10</th>\n",
       "      <th>Unnamed: 11</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Biguanide</td>\n",
       "      <td>Metformin</td>\n",
       "      <td>Glucophage, Fortamet, Glutetza, Riomet</td>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glipizide</td>\n",
       "      <td>Severe</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Increased Risk of Cardiovascular Disease or Al...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Thiazolidinediones (TZD)</td>\n",
       "      <td>rosiglitazone</td>\n",
       "      <td>Avandia</td>\n",
       "      <td>Sulfonylureas (couldn't find a drug advised ag...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Minor</td>\n",
       "      <td>positive mechanism</td>\n",
       "      <td>very slight hypoglycemia effects, but mostly p...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>GLP1 mimetics</td>\n",
       "      <td>albiglutide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>glipizide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>GLP 1 receptor agonists stimulate insulin secr...</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>GLP1 mimetics</td>\n",
       "      <td>dulaglutide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>repaglinide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>GLP 1 receptor agonists stimulate insulin secr...</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>GLP1 mimetics</td>\n",
       "      <td>exenatide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>glipizide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>GLP 1 receptor agonists stimulate insulin secr...</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>GLP1 mimetics</td>\n",
       "      <td>liraglutide</td>\n",
       "      <td>victoza</td>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>repaglinide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>GLP 1 receptor agonists stimulate insulin secr...</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>GLP1 mimetics</td>\n",
       "      <td>lixisenatide</td>\n",
       "      <td>soliqua, insulin glargine</td>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>glipizide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>GLP 1 receptor agonists stimulate insulin secr...</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>GLP1 mimetics</td>\n",
       "      <td>semaglutide</td>\n",
       "      <td>ozempic</td>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>repaglinide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>GLP 1 receptor agonists stimulate insulin secr...</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>DPP4</td>\n",
       "      <td>alogliptin</td>\n",
       "      <td>Nesina, Vipidia</td>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>repaglinide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>DPP4</td>\n",
       "      <td>linagliptin</td>\n",
       "      <td>tradjenta</td>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>nateglinide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>DPP4</td>\n",
       "      <td>saxagliptin</td>\n",
       "      <td>Onglyza</td>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>repaglinide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>DPP4</td>\n",
       "      <td>sitagliptin</td>\n",
       "      <td>Januvia</td>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>nateglinide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Alpha-glucosidase inhibitor</td>\n",
       "      <td>acarbose</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Alpha-glucosidase inhibitor</td>\n",
       "      <td>miglitol</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>nateglinide</td>\n",
       "      <td>Starlix</td>\n",
       "      <td>DPP4</td>\n",
       "      <td>Saxagliptin</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>repaglinide</td>\n",
       "      <td>prandin</td>\n",
       "      <td>DPP4</td>\n",
       "      <td>Sitagliptin</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>chlorpropamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fluconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>chlorpropamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Miconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glimepiride</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fluconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glimepiride</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Miconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glipizide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fluconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glipizide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Miconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glyburide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fluconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glyburide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Miconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>tolbutamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fluconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>tolbutamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Miconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>tolazamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fluconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>tolazamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Miconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>gliclazide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fluconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>gliclazide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Miconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>SGLT2 inhibitors</td>\n",
       "      <td>canagliflozin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Insulin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>SGLT2 inhibitors</td>\n",
       "      <td>dapagliflozin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Insulin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elevated risk of hypoglycemia, UTI's and genit...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>SGLT2 inhibitors</td>\n",
       "      <td>empagliflozin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Insulin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>SGLT2 inhibitors</td>\n",
       "      <td>ertugliflozin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Insulin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>chlorpropamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fibrates</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>chlorpropamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>H2-antagonoists</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glimepiride</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fibrates</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glimepiride</td>\n",
       "      <td>NaN</td>\n",
       "      <td>H2-antagonoists</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glipizide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fibrates</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glipizide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>H2-antagonoists</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glyburide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fibrates</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>glyburide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>H2-antagonoists</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>tolbutamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fibrates</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>tolbutamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>H2-antagonoists</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>tolazamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fibrates</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>tolazamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>H2-antagonoists</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>gliclazide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fibrates</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>gliclazide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>H2-antagonoists</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>SGLT2 inhibitors</td>\n",
       "      <td>canagliflozin</td>\n",
       "      <td>Invokana</td>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Reduces the SGLT 2 protein in the kidney to in...</td>\n",
       "      <td>Can result to hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>SGLT2 inhibitors</td>\n",
       "      <td>dapagliflozin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>SGLT2 inhibitors</td>\n",
       "      <td>empagliflozin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>SGLT2 inhibitors</td>\n",
       "      <td>ertugliflozin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>nateglinide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>GLP1 mimetics</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Meglitinides</td>\n",
       "      <td>repaglinide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>GLP1 mimetics</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>Biguanide</td>\n",
       "      <td>Metformin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cimetidine</td>\n",
       "      <td>Mild</td>\n",
       "      <td>Inhibition of renal excretion</td>\n",
       "      <td>plasma values and adverse event rate increase</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>Biguanide</td>\n",
       "      <td>Metformin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>cephalexin</td>\n",
       "      <td>Mild</td>\n",
       "      <td>Inhibition of renal excretion</td>\n",
       "      <td>plasma values and adverse event rate increase</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Biguanide</td>\n",
       "      <td>Metformin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>pyrimethamine</td>\n",
       "      <td>Mild</td>\n",
       "      <td>Inhibition of renal excretion</td>\n",
       "      <td>plasma values and adverse event rate increase</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>Biguanide</td>\n",
       "      <td>Metformin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Anticholinergics</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Mild</td>\n",
       "      <td>Elevated gastrointestinal absorption by altere...</td>\n",
       "      <td>plasma values and adverse event rate increase</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>Biguanide</td>\n",
       "      <td>Metformin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Iodinated contrast media</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Severe</td>\n",
       "      <td>Elevated risk of contrast media induced nephro...</td>\n",
       "      <td>plasma values and adverse event rate increase</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                          Class          Source  \\\n",
       "0                     Biguanide       Metformin   \n",
       "1      Thiazolidinediones (TZD)   rosiglitazone   \n",
       "2                 GLP1 mimetics     albiglutide   \n",
       "3                 GLP1 mimetics     dulaglutide   \n",
       "4                 GLP1 mimetics       exenatide   \n",
       "5                 GLP1 mimetics     liraglutide   \n",
       "6                 GLP1 mimetics    lixisenatide   \n",
       "7                 GLP1 mimetics     semaglutide   \n",
       "8                          DPP4      alogliptin   \n",
       "9                          DPP4     linagliptin   \n",
       "10                         DPP4     saxagliptin   \n",
       "11                         DPP4     sitagliptin   \n",
       "12  Alpha-glucosidase inhibitor        acarbose   \n",
       "13  Alpha-glucosidase inhibitor        miglitol   \n",
       "14                 Meglitinides     nateglinide   \n",
       "15                 Meglitinides     repaglinide   \n",
       "16                Sulfonylureas  chlorpropamide   \n",
       "17                Sulfonylureas  chlorpropamide   \n",
       "18                Sulfonylureas     glimepiride   \n",
       "19                Sulfonylureas     glimepiride   \n",
       "20                Sulfonylureas       glipizide   \n",
       "21                Sulfonylureas       glipizide   \n",
       "22                Sulfonylureas       glyburide   \n",
       "23                Sulfonylureas       glyburide   \n",
       "24                Sulfonylureas     tolbutamide   \n",
       "25                Sulfonylureas     tolbutamide   \n",
       "26                Sulfonylureas      tolazamide   \n",
       "27                Sulfonylureas      tolazamide   \n",
       "28                Sulfonylureas      gliclazide   \n",
       "29                Sulfonylureas      gliclazide   \n",
       "30             SGLT2 inhibitors   canagliflozin   \n",
       "31             SGLT2 inhibitors   dapagliflozin   \n",
       "32             SGLT2 inhibitors   empagliflozin   \n",
       "33             SGLT2 inhibitors   ertugliflozin   \n",
       "34                Sulfonylureas  chlorpropamide   \n",
       "35                Sulfonylureas  chlorpropamide   \n",
       "36                Sulfonylureas     glimepiride   \n",
       "37                Sulfonylureas     glimepiride   \n",
       "38                Sulfonylureas       glipizide   \n",
       "39                Sulfonylureas       glipizide   \n",
       "40                Sulfonylureas       glyburide   \n",
       "41                Sulfonylureas       glyburide   \n",
       "42                Sulfonylureas     tolbutamide   \n",
       "43                Sulfonylureas     tolbutamide   \n",
       "44                Sulfonylureas      tolazamide   \n",
       "45                Sulfonylureas      tolazamide   \n",
       "46                Sulfonylureas      gliclazide   \n",
       "47                Sulfonylureas      gliclazide   \n",
       "48             SGLT2 inhibitors   canagliflozin   \n",
       "49             SGLT2 inhibitors   dapagliflozin   \n",
       "50             SGLT2 inhibitors   empagliflozin   \n",
       "51             SGLT2 inhibitors   ertugliflozin   \n",
       "52                 Meglitinides     nateglinide   \n",
       "53                 Meglitinides     repaglinide   \n",
       "54                    Biguanide       Metformin   \n",
       "55                    Biguanide       Metformin   \n",
       "56                    Biguanide       Metformin   \n",
       "57                    Biguanide       Metformin   \n",
       "58                    Biguanide       Metformin   \n",
       "\n",
       "                           Alternate Names  \\\n",
       "0   Glucophage, Fortamet, Glutetza, Riomet   \n",
       "1                                  Avandia   \n",
       "2                                      NaN   \n",
       "3                                      NaN   \n",
       "4                                      NaN   \n",
       "5                                 victoza    \n",
       "6                soliqua, insulin glargine   \n",
       "7                                 ozempic    \n",
       "8                          Nesina, Vipidia   \n",
       "9                               tradjenta    \n",
       "10                                 Onglyza   \n",
       "11                                 Januvia   \n",
       "12                                     NaN   \n",
       "13                                     NaN   \n",
       "14                                 Starlix   \n",
       "15                                 prandin   \n",
       "16                                     NaN   \n",
       "17                                     NaN   \n",
       "18                                     NaN   \n",
       "19                                     NaN   \n",
       "20                                     NaN   \n",
       "21                                     NaN   \n",
       "22                                     NaN   \n",
       "23                                     NaN   \n",
       "24                                     NaN   \n",
       "25                                     NaN   \n",
       "26                                     NaN   \n",
       "27                                     NaN   \n",
       "28                                     NaN   \n",
       "29                                     NaN   \n",
       "30                                     NaN   \n",
       "31                                     NaN   \n",
       "32                                     NaN   \n",
       "33                                     NaN   \n",
       "34                                     NaN   \n",
       "35                                     NaN   \n",
       "36                                     NaN   \n",
       "37                                     NaN   \n",
       "38                                     NaN   \n",
       "39                                     NaN   \n",
       "40                                     NaN   \n",
       "41                                     NaN   \n",
       "42                                     NaN   \n",
       "43                                     NaN   \n",
       "44                                     NaN   \n",
       "45                                     NaN   \n",
       "46                                     NaN   \n",
       "47                                     NaN   \n",
       "48                                Invokana   \n",
       "49                                     NaN   \n",
       "50                                     NaN   \n",
       "51                                     NaN   \n",
       "52                                     NaN   \n",
       "53                                     NaN   \n",
       "54                                     NaN   \n",
       "55                                     NaN   \n",
       "56                                     NaN   \n",
       "57                                     NaN   \n",
       "58                                     NaN   \n",
       "\n",
       "                                        Adverse Class    Single Drug  \\\n",
       "0                                       Sulfonylureas     glipizide    \n",
       "1   Sulfonylureas (couldn't find a drug advised ag...            NaN   \n",
       "2                                        Meglitinides     glipizide    \n",
       "3                                        Meglitinides    repaglinide   \n",
       "4                                        Meglitinides     glipizide    \n",
       "5                                        Meglitinides    repaglinide   \n",
       "6                                        Meglitinides     glipizide    \n",
       "7                                        Meglitinides    repaglinide   \n",
       "8                                        Meglitinides    repaglinide   \n",
       "9                                        Meglitinides    nateglinide   \n",
       "10                                       Meglitinides    repaglinide   \n",
       "11                                       Meglitinides    nateglinide   \n",
       "12                                                NaN            NaN   \n",
       "13                                                NaN            NaN   \n",
       "14                                               DPP4    Saxagliptin   \n",
       "15                                               DPP4    Sitagliptin   \n",
       "16                                                NaN    Fluconazole   \n",
       "17                                                NaN     Miconazole   \n",
       "18                                                NaN    Fluconazole   \n",
       "19                                                NaN     Miconazole   \n",
       "20                                                NaN    Fluconazole   \n",
       "21                                                NaN     Miconazole   \n",
       "22                                                NaN    Fluconazole   \n",
       "23                                                NaN     Miconazole   \n",
       "24                                                NaN    Fluconazole   \n",
       "25                                                NaN     Miconazole   \n",
       "26                                                NaN    Fluconazole   \n",
       "27                                                NaN     Miconazole   \n",
       "28                                                NaN    Fluconazole   \n",
       "29                                                NaN     Miconazole   \n",
       "30                                            Insulin            NaN   \n",
       "31                                            Insulin            NaN   \n",
       "32                                            Insulin            NaN   \n",
       "33                                            Insulin            NaN   \n",
       "34                                           Fibrates            NaN   \n",
       "35                                    H2-antagonoists            NaN   \n",
       "36                                           Fibrates            NaN   \n",
       "37                                    H2-antagonoists            NaN   \n",
       "38                                           Fibrates            NaN   \n",
       "39                                    H2-antagonoists            NaN   \n",
       "40                                           Fibrates            NaN   \n",
       "41                                    H2-antagonoists            NaN   \n",
       "42                                           Fibrates            NaN   \n",
       "43                                    H2-antagonoists            NaN   \n",
       "44                                           Fibrates            NaN   \n",
       "45                                    H2-antagonoists            NaN   \n",
       "46                                           Fibrates            NaN   \n",
       "47                                    H2-antagonoists            NaN   \n",
       "48                                      Sulfonylureas            NaN   \n",
       "49                                      Sulfonylureas            NaN   \n",
       "50                                      Sulfonylureas            NaN   \n",
       "51                                      Sulfonylureas            NaN   \n",
       "52                                      GLP1 mimetics            NaN   \n",
       "53                                      GLP1 mimetics            NaN   \n",
       "54                                                NaN     Cimetidine   \n",
       "55                                                NaN     cephalexin   \n",
       "56                                                NaN  pyrimethamine   \n",
       "57                                   Anticholinergics            NaN   \n",
       "58                           Iodinated contrast media            NaN   \n",
       "\n",
       "   Classification of Risk                                          Mechanism  \\\n",
       "0                  Severe                                                NaN   \n",
       "1                  Minor                                  positive mechanism   \n",
       "2                Moderate  GLP 1 receptor agonists stimulate insulin secr...   \n",
       "3                Moderate  GLP 1 receptor agonists stimulate insulin secr...   \n",
       "4                Moderate  GLP 1 receptor agonists stimulate insulin secr...   \n",
       "5                Moderate  GLP 1 receptor agonists stimulate insulin secr...   \n",
       "6                Moderate  GLP 1 receptor agonists stimulate insulin secr...   \n",
       "7                Moderate  GLP 1 receptor agonists stimulate insulin secr...   \n",
       "8                Moderate                                                NaN   \n",
       "9                Moderate                                                NaN   \n",
       "10               Moderate                                                NaN   \n",
       "11               Moderate                                                NaN   \n",
       "12                    NaN                                                NaN   \n",
       "13                    NaN                                                NaN   \n",
       "14               Moderate                                                NaN   \n",
       "15               Moderate                                                NaN   \n",
       "16               Moderate                               Inhibition of CYP2C9   \n",
       "17               Moderate                               Inhibition of CYP2C9   \n",
       "18               Moderate                               Inhibition of CYP2C9   \n",
       "19               Moderate                               Inhibition of CYP2C9   \n",
       "20               Moderate                               Inhibition of CYP2C9   \n",
       "21               Moderate                               Inhibition of CYP2C9   \n",
       "22               Moderate                               Inhibition of CYP2C9   \n",
       "23               Moderate                               Inhibition of CYP2C9   \n",
       "24               Moderate                               Inhibition of CYP2C9   \n",
       "25               Moderate                               Inhibition of CYP2C9   \n",
       "26               Moderate                               Inhibition of CYP2C9   \n",
       "27               Moderate                               Inhibition of CYP2C9   \n",
       "28               Moderate                               Inhibition of CYP2C9   \n",
       "29               Moderate                               Inhibition of CYP2C9   \n",
       "30               Moderate                                                NaN   \n",
       "31               Moderate                                                NaN   \n",
       "32                    NaN                                                NaN   \n",
       "33                    NaN                                                NaN   \n",
       "34               Moderate                               Inhibition of CYP2C9   \n",
       "35               Moderate                               Inhibition of CYP2C9   \n",
       "36               Moderate                               Inhibition of CYP2C9   \n",
       "37               Moderate                               Inhibition of CYP2C9   \n",
       "38               Moderate                               Inhibition of CYP2C9   \n",
       "39               Moderate                               Inhibition of CYP2C9   \n",
       "40               Moderate                               Inhibition of CYP2C9   \n",
       "41               Moderate                               Inhibition of CYP2C9   \n",
       "42               Moderate                               Inhibition of CYP2C9   \n",
       "43               Moderate                               Inhibition of CYP2C9   \n",
       "44               Moderate                               Inhibition of CYP2C9   \n",
       "45               Moderate                               Inhibition of CYP2C9   \n",
       "46               Moderate                               Inhibition of CYP2C9   \n",
       "47               Moderate                               Inhibition of CYP2C9   \n",
       "48               Moderate  Reduces the SGLT 2 protein in the kidney to in...   \n",
       "49               Moderate                                                NaN   \n",
       "50               Moderate                                                NaN   \n",
       "51               Moderate                                                NaN   \n",
       "52               Moderate                                                NaN   \n",
       "53               Moderate                                                NaN   \n",
       "54                   Mild                      Inhibition of renal excretion   \n",
       "55                   Mild                      Inhibition of renal excretion   \n",
       "56                   Mild                      Inhibition of renal excretion   \n",
       "57                   Mild  Elevated gastrointestinal absorption by altere...   \n",
       "58                 Severe  Elevated risk of contrast media induced nephro...   \n",
       "\n",
       "                                       Adverse Effect  Unnamed: 8  Unnamed: 9  \\\n",
       "0   Increased Risk of Cardiovascular Disease or Al...         NaN         NaN   \n",
       "1   very slight hypoglycemia effects, but mostly p...         NaN         NaN   \n",
       "2                                  hypoglycemia risks         NaN         NaN   \n",
       "3                                  hypoglycemia risks         NaN         NaN   \n",
       "4                                  hypoglycemia risks         NaN         NaN   \n",
       "5                                  hypoglycemia risks         NaN         NaN   \n",
       "6                                  hypoglycemia risks         NaN         NaN   \n",
       "7                                  hypoglycemia risks         NaN         NaN   \n",
       "8                                  hypoglycemia risks         NaN         NaN   \n",
       "9                                  hypoglycemia risks         NaN         NaN   \n",
       "10                                 hypoglycemia risks         NaN         NaN   \n",
       "11                                 hypoglycemia risks         NaN         NaN   \n",
       "12                                                NaN         NaN         NaN   \n",
       "13                                                NaN         NaN         NaN   \n",
       "14                                 hypoglycemia risks         NaN         NaN   \n",
       "15                                 hypoglycemia risks         NaN         NaN   \n",
       "16                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "17                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "18                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "19                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "20                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "21                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "22                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "23                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "24                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "25                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "26                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "27                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "28                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "29                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "30                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "31  Elevated risk of hypoglycemia, UTI's and genit...         NaN         NaN   \n",
       "32                                                NaN         NaN         NaN   \n",
       "33                                                NaN         NaN         NaN   \n",
       "34                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "35                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "36                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "37                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "38                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "39                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "40                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "41                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "42                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "43                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "44                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "45                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "46                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "47                      Elevated risk of hypoglycemia         NaN         NaN   \n",
       "48                         Can result to hypoglycemia         NaN         NaN   \n",
       "49                                                NaN         NaN         NaN   \n",
       "50                                                NaN         NaN         NaN   \n",
       "51                                                NaN         NaN         NaN   \n",
       "52                                                NaN         NaN         NaN   \n",
       "53                                                NaN         NaN         NaN   \n",
       "54      plasma values and adverse event rate increase         NaN         NaN   \n",
       "55      plasma values and adverse event rate increase         NaN         NaN   \n",
       "56      plasma values and adverse event rate increase         NaN         NaN   \n",
       "57      plasma values and adverse event rate increase         NaN         NaN   \n",
       "58      plasma values and adverse event rate increase         NaN         NaN   \n",
       "\n",
       "    Unnamed: 10  Unnamed: 11  \n",
       "0           NaN          NaN  \n",
       "1           NaN          NaN  \n",
       "2           NaN          NaN  \n",
       "3           NaN          NaN  \n",
       "4           NaN          NaN  \n",
       "5           NaN          NaN  \n",
       "6           NaN          NaN  \n",
       "7           NaN          NaN  \n",
       "8           NaN          NaN  \n",
       "9           NaN          NaN  \n",
       "10          NaN          NaN  \n",
       "11          NaN          NaN  \n",
       "12          NaN          NaN  \n",
       "13          NaN          NaN  \n",
       "14          NaN          NaN  \n",
       "15          NaN          NaN  \n",
       "16          NaN          NaN  \n",
       "17          NaN          NaN  \n",
       "18          NaN          NaN  \n",
       "19          NaN          NaN  \n",
       "20          NaN          NaN  \n",
       "21          NaN          NaN  \n",
       "22          NaN          NaN  \n",
       "23          NaN          NaN  \n",
       "24          NaN          NaN  \n",
       "25          NaN          NaN  \n",
       "26          NaN          NaN  \n",
       "27          NaN          NaN  \n",
       "28          NaN          NaN  \n",
       "29          NaN          NaN  \n",
       "30          NaN          NaN  \n",
       "31          NaN          NaN  \n",
       "32          NaN          NaN  \n",
       "33          NaN          NaN  \n",
       "34          NaN          NaN  \n",
       "35          NaN          NaN  \n",
       "36          NaN          NaN  \n",
       "37          NaN          NaN  \n",
       "38          NaN          NaN  \n",
       "39          NaN          NaN  \n",
       "40          NaN          NaN  \n",
       "41          NaN          NaN  \n",
       "42          NaN          NaN  \n",
       "43          NaN          NaN  \n",
       "44          NaN          NaN  \n",
       "45          NaN          NaN  \n",
       "46          NaN          NaN  \n",
       "47          NaN          NaN  \n",
       "48          NaN          NaN  \n",
       "49          NaN          NaN  \n",
       "50          NaN          NaN  \n",
       "51          NaN          NaN  \n",
       "52          NaN          NaN  \n",
       "53          NaN          NaN  \n",
       "54          NaN          NaN  \n",
       "55          NaN          NaN  \n",
       "56          NaN          NaN  \n",
       "57          NaN          NaN  \n",
       "58          NaN          NaN  "
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "df = pd.read_csv('Diabetes_Drug-Drug_Interactions.csv')\n",
    "df = df.rename({\"Drug\": \"Source\", \"Not Advised With (Specific Drug, no need to list drugs if they belong to a class that's in the previous column)\": \"Single Drug\", \"Not Advised With (Class of Drug, put SINGULAR!)\": \"Adverse Class\"}, axis=1)\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"First write out straightforward source - target - label triplets\"\"\"\n",
    "df_singles = df[df['Single Drug'].notna()] # slice dataframe to just see\n",
    "# need to map from \"Adverse Class\" to \"Class\" column and fetch those drugs \n",
    "df_singles = df_singles[['Source', 'Single Drug', 'Classification of Risk', 'Adverse Effect']]\n",
    "df_singles = df_singles.rename({\"Source\": 'source', 'Single Drug': 'target', 'Classification of Risk': 'label', 'Adverse Effect' : 'description'}, axis=1)\n",
    "df_singles.to_csv('./ddis_from_spreadsheet.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "def add_list(drug_class, drug_class_mappings):\n",
    "    try:\n",
    "        return drug_class_mappings[drug_class]\n",
    "    except:\n",
    "        return None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"1. Look for individual drugs that have an Adverse Class\"\"\"\n",
    "drugs_with_adverse_class = df[df['Adverse Class'].notna()]\n",
    "\n",
    "\"\"\"2. Get mapping of class:drugs in that class\"\"\"\n",
    "classes = set(df['Class'])\n",
    "# need to get the union of adverse classes and regular classes\n",
    "adv_classes = set(df['Adverse Class'])\n",
    "classes = classes.union(adv_classes)\n",
    "\n",
    "class_mapping = {}\n",
    "for class_ in classes:\n",
    "    drugs_in_class = set(df[df['Class'] == class_]['Source'])\n",
    "    class_mapping[class_] = drugs_in_class\n",
    "# print(class_mapping)\n",
    "\n",
    "\"\"\"2. For every drug with an Adverse Class, find the drugs that correspond to that class and create edges.\"\"\"\n",
    "df_new = df.copy()\n",
    "df_new['Drugs in Adverse Class'] = drugs_with_adverse_class['Adverse Class'].apply(add_list, drug_class_mappings = class_mapping)\n",
    "df_new = df_new.explode('Drugs in Adverse Class')\n",
    "df_classes_slice = df_new[['Source', 'Drugs in Adverse Class', 'Classification of Risk','Adverse Effect']]\n",
    "\n",
    "# now remove triples with no Single Drug\n",
    "df_classes_rm = df_classes_slice.dropna(subset=['Drugs in Adverse Class'])\n",
    "df_classes_rm.to_csv('./ddis_from_spreadsheet.csv', mode='a', header=False, index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{nan: set(),\n",
       " 'Fibrates': set(),\n",
       " 'Sulfonylureas': {'chlorpropamide',\n",
       "  'gliclazide',\n",
       "  'glimepiride',\n",
       "  'glipizide',\n",
       "  'glyburide',\n",
       "  'tolazamide',\n",
       "  'tolbutamide'},\n",
       " 'Insulin': set(),\n",
       " 'H2-antagonoists': set(),\n",
       " 'DPP4': {'alogliptin', 'linagliptin', 'saxagliptin', 'sitagliptin'},\n",
       " 'Iodinated contrast media': set(),\n",
       " \"Sulfonylureas (couldn't find a drug advised against, so found a drug worked well with) + Metformin\": set(),\n",
       " 'SGLT2 inhibitors': {'canagliflozin',\n",
       "  'dapagliflozin',\n",
       "  'empagliflozin',\n",
       "  'ertugliflozin'},\n",
       " 'Thiazolidinediones (TZD)': {'rosiglitazone'},\n",
       " 'Alpha-glucosidase inhibitor': {'acarbose', 'miglitol'},\n",
       " 'Meglitinides': {'nateglinide', 'repaglinide'},\n",
       " 'Biguanide': {'Metformin'},\n",
       " 'Anticholinergics': set(),\n",
       " 'GLP1 mimetics': {'albiglutide',\n",
       "  'dulaglutide',\n",
       "  'exenatide',\n",
       "  'liraglutide',\n",
       "  'lixisenatide',\n",
       "  'semaglutide'}}"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "class_mapping"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Class</th>\n",
       "      <th>Source</th>\n",
       "      <th>Alternate Names</th>\n",
       "      <th>Adverse Class</th>\n",
       "      <th>Single Drug</th>\n",
       "      <th>Classification of Risk</th>\n",
       "      <th>Mechanism</th>\n",
       "      <th>Adverse Effect</th>\n",
       "      <th>Unnamed: 8</th>\n",
       "      <th>Unnamed: 9</th>\n",
       "      <th>Unnamed: 10</th>\n",
       "      <th>Unnamed: 11</th>\n",
       "      <th>Drugs in Adverse Class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>chlorpropamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fluconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>chlorpropamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Miconazole</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>chlorpropamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fibrates</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Sulfonylureas</td>\n",
       "      <td>chlorpropamide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>H2-antagonoists</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>Inhibition of CYP2C9</td>\n",
       "      <td>Elevated risk of hypoglycemia</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            Class          Source Alternate Names    Adverse Class  \\\n",
       "16  Sulfonylureas  chlorpropamide             NaN              NaN   \n",
       "17  Sulfonylureas  chlorpropamide             NaN              NaN   \n",
       "34  Sulfonylureas  chlorpropamide             NaN         Fibrates   \n",
       "35  Sulfonylureas  chlorpropamide             NaN  H2-antagonoists   \n",
       "\n",
       "    Single Drug Classification of Risk             Mechanism  \\\n",
       "16  Fluconazole               Moderate  Inhibition of CYP2C9   \n",
       "17   Miconazole               Moderate  Inhibition of CYP2C9   \n",
       "34          NaN               Moderate  Inhibition of CYP2C9   \n",
       "35          NaN               Moderate  Inhibition of CYP2C9   \n",
       "\n",
       "                   Adverse Effect  Unnamed: 8  Unnamed: 9  Unnamed: 10  \\\n",
       "16  Elevated risk of hypoglycemia         NaN         NaN          NaN   \n",
       "17  Elevated risk of hypoglycemia         NaN         NaN          NaN   \n",
       "34  Elevated risk of hypoglycemia         NaN         NaN          NaN   \n",
       "35  Elevated risk of hypoglycemia         NaN         NaN          NaN   \n",
       "\n",
       "    Unnamed: 11 Drugs in Adverse Class  \n",
       "16          NaN                    NaN  \n",
       "17          NaN                    NaN  \n",
       "34          NaN                    NaN  \n",
       "35          NaN                    NaN  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_new[df_new['Source'] == 'chlorpropamide']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Source</th>\n",
       "      <th>Drugs in Adverse Class</th>\n",
       "      <th>Classification of Risk</th>\n",
       "      <th>Adverse Effect</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>nateglinide</td>\n",
       "      <td>alogliptin</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>nateglinide</td>\n",
       "      <td>sitagliptin</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>nateglinide</td>\n",
       "      <td>saxagliptin</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>nateglinide</td>\n",
       "      <td>linagliptin</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>hypoglycemia risks</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>nateglinide</td>\n",
       "      <td>lixisenatide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>nateglinide</td>\n",
       "      <td>liraglutide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>nateglinide</td>\n",
       "      <td>albiglutide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>nateglinide</td>\n",
       "      <td>exenatide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>nateglinide</td>\n",
       "      <td>dulaglutide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>nateglinide</td>\n",
       "      <td>semaglutide</td>\n",
       "      <td>Moderate</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         Source Drugs in Adverse Class Classification of Risk  \\\n",
       "14  nateglinide             alogliptin               Moderate   \n",
       "14  nateglinide            sitagliptin               Moderate   \n",
       "14  nateglinide            saxagliptin               Moderate   \n",
       "14  nateglinide            linagliptin               Moderate   \n",
       "52  nateglinide           lixisenatide               Moderate   \n",
       "52  nateglinide            liraglutide               Moderate   \n",
       "52  nateglinide            albiglutide               Moderate   \n",
       "52  nateglinide              exenatide               Moderate   \n",
       "52  nateglinide            dulaglutide               Moderate   \n",
       "52  nateglinide            semaglutide               Moderate   \n",
       "\n",
       "        Adverse Effect  \n",
       "14  hypoglycemia risks  \n",
       "14  hypoglycemia risks  \n",
       "14  hypoglycemia risks  \n",
       "14  hypoglycemia risks  \n",
       "52                 NaN  \n",
       "52                 NaN  \n",
       "52                 NaN  \n",
       "52                 NaN  \n",
       "52                 NaN  \n",
       "52                 NaN  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_classes_slice[df_classes_slice['Source'] == 'nateglinide']"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.15"
  },
  "vscode": {
   "interpreter": {
    "hash": "aee8b7b246df8f9039afb4144a1f6fd8d2ca17a180786b69acc140d282b71a49"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
